title: Case seminar: a young female with acute hyponatremia and a sellar mass.
abstract: In familial cases of combined pituitary hormone deficiency the most common mutations are that of Prophet of Pit 1 (PROP1) gene. PROP1 mutations are associated with deficiencies of growth hormone, thyrotropin, prolactin, and gonadotropins (follicle-stimulating hormone and luteinizing hormone), with evolving adrenocorticotropin (ACTH) deficiency in some cases. On imaging in most patients the pituitary gland is hypoplastic, but occasionally transient pituitary enlargement is found. We report a 22-year-old female initially diagnosed at age 12 with familial hypopituitarism due to PROP1 mutation, who presented with coma and respiratory arrest (acute hyponatremia). She was urgently treated in Intensive Care Unit of Emergency Center with hypertonic saline and stress doses of hydrocortisone, which resulted in the fast increase of plasma osmolality resulting in the osmotic demyelination syndrome. Simultaneously and incidentally on computed tomography scan a large sellar and suprasellar mass were reported as possible Rathke's cleft cyst or craniopharyngioma. Once the patient was stable, ACTH deficiency was documented. She remained replaced with hydrocortisone and subsequently underwent transphenoidal surgery. The removed sellar content revealed no pituitary adenoma or pituitary cells, but only an eosinophilic, colloid-like mass, and necrotic acellular debris. Her sister with hypopituitarism had an empty sella. Genetic testing in both sisters revealed the same homozygous c.150delA mutation in PROP1 gene. Here we report two sisters with the same PROP1 mutation who presented in adulthood with different pituitary morphology, one of them with a large sellar and suprasellar mass, in which transphenoidal surgery provided an extremely rare opportunity for a histopathological analysis of the sellar content. Due to the lack of endocrine care during the transition period hypocortisolism which evolved, a consequence of PROP1 mutation, was not recognized. Empirical use of hydrocortisone in the Intensive Care in our patient with life-threatening acute hyponatremia was appropriate but because glucocorticoid therapy on its own corrects hyponatremia even after stopping hypertonic saline infusion, the risk for over-correction of hyponatremia in ACTH deficiency is high.
authors.affiliation: Clinic of Endocrinology, Clinical Center Serbia, Belgrade, Serbia.
authors.forename: Sandra
authors.initials: S
authors.lastname: Pekic
authors.forename: Mirjana
authors.initials: M
authors.lastname: Doknic
authors.forename: Dragana
authors.initials: D
authors.lastname: Miljic
authors.forename: Alexandru
authors.initials: A
authors.lastname: Saveanu
authors.forename: Rachel
authors.initials: R
authors.lastname: Reynaud
authors.forename: Anne
authors.initials: A
authors.lastname: Barlier
authors.forename: Thierry
authors.initials: T
authors.lastname: Brue
authors.forename: Vera
authors.initials: V
authors.lastname: Popovic
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000097:blood / Q000172:deficiency*; D002648:Child; D005260:Female; D018398:Homeodomain Proteins / Q000235:genetics*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007010:Hyponatremia / Q000097:blood / Q000209:etiology* / Q000235:genetics / Q000473:pathology / Q000628:therapy; D007018:Hypopituitarism / Q000097:blood / Q000150:complications* / Q000235:genetics / Q000473:pathology / Q000628:therapy; D010902:Pituitary Gland / Q000002:abnormalities* / Q000473:pathology; D012658:Sella Turcica / Q000473:pathology; D017384:Sequence Deletion; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000305:Adrenal Cortex Hormones; D018398:Homeodomain Proteins; C102134:Prophet of Pit-1 protein; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone